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ABSTRACT  
We have previously shown that Rab17 - a small GTPase associated with epithelial polarity - 
is specifically suppressed by ERK2 signalling to promote an invasive phenotype. However, 
the mechanisms through which Rab17 loss permits invasiveness, and the endosomal 
cargoes that are responsible for mediating this are not known. Using quantitative mass 
spectrometry-based proteomics, we have found that knockdown of Rab17 leads to highly 
selective reduction in the cellular levels of a v-SNARE (Vamp8).  Moreover, proteomics and 
immunofluorescence indicate that Vamp-8 is associated with Rab17 at late endosomes. 
Reduced levels of Vamp8 promote transition between ductal carcinoma in situ (DCIS) and a 
more invasive phenotype. We developed an unbiased proteomic approach to elucidate the 
complement of receptors that redistributes between endosomes and the plasma membrane, 
and have pin-pointed neuropilin-2 (NRP2) as a key pro-invasive cargo of Rab17/Vamp8-
regulated trafficking.  Indeed, reduced Rab17 or Vamp8 levels lead to increased mobilisation 
of NRP2-containing late endosomes and upregulated cell surface expression of NRP2. 
Finally, we show that NRP2 is required for the basement membrane disruption which 
accompanies transition between DCIS and a more invasive phenotype. 
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INTRODUCTION 
The membrane trafficking events controlled by Rab GTPases influence cellular processes 
that accompany cancer initiation and progression, including loss of cell polarity, and the drive 
to invasion and metastasis (Cox et al, 2014; De Franceschi et al, 2015; Goldenring, 2013).  
The contribution made by Rab GTPases to acquisition of invasive behaviour has been 
intensively studied, and the molecular machinery which is responsible for trafficking 
receptors controlling cell adhesion and cell migration is becoming well-understood (Miller et 
al, 2000; Rainero & Norman, 2013).  There is good evidence that Rab11 GTPase control of 
integrin and receptor tyrosine kinase (RTK) recycling drives invasive migration in cancer, 
and expression of Rab11s and their effectors, such as Rab-coupling protein (RCP) is linked 
to metastasis (Caswell et al, 2008).  Furthermore, Rab21 is closely associated with integrin 
trafficking and the contribution made by this Rab GTPase to cancer invasiveness and 
suppression of apoptosis is now well-documented (Alanko et al, 2015; Hognas et al, 2012).   
Loss of epithelial cell polarity is a key event in cancer progression, and one that is generally 
accepted to precede acquisition of invasive and metastatic capabilities (McCaffrey & 
Macara, 2011).  For example, in breast cancer, epithelial polarity is progressively lost as 
tumours progress from pre-malignant lesions to invasive carcinoma.  Ductal carcinoma in 
situ (DCIS), which are a heterogeneous group of lesions characterised by intraductal 
proliferation of malignant epithelial cells, possess an intact basement membrane (which may 
be considered to be a remnant basolateral domain) but the cells display no functional apical 
surface (Wiechmann & Kuerer, 2008). The progression of DCIS to invasive ductal carcinoma 
(IDC) occurs when the basement membrane becomes disrupted and this last vestige of 
epithelial polarity is lost.  Despite the fact that transition between DCIS and IDC is an 
accepted watershed in disease aggressiveness, the key molecular and cellular drivers of this 
process are not well understood (Clark et al, 2011; Hannemann et al, 2006; Vincent-
Salomon et al, 2008).  Since the DCIS to IDC transition involves loss of aspects of epithelial 
polarity, this is likely to be driven by alterations to Rab GTPase levels and/or function.  It is 
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already known that Rab25, a Rab11 GTPase whose expression is largely restricted to 
epithelia, is often lost in breast cancer (Cheng et al, 2010), and deletion of Rab25 
accelerates tumourigenesis in a mouse model of colon cancer (Nam et al, 2010).  One 
interpretation of this is that loss of Rab25 leads to disruption of trafficking pathways that 
maintain aspects of normal epithelial polarity.  Rab17 was the first epithelial cell specific 
small GTPases to be identified, and its expression is induced as epithelial cells polarise 
(Hunziker & Peters, 1998; Lutcke et al, 1993; Zacchi et al, 1998). There is some debate as 
to the trafficking pathways controlled by Rab17, but a consensus is emerging that this Rab 
GTPase is associated with transcytosis of receptors, such as the polymeric immune globulin 
receptor (dlgA) and the transferrin receptor (TfnR) from the basolateral to the apical surface 
of epithelial cells (Hansen et al, 1999; Zacchi et al, 1998).  We have recently identified 
Rab17 as a gene which is suppressed during the acquisition of invasive migration that 
accompanies upregulation of ERK2 kinase signalling (von Thun et al, 2012).  Furthermore, 
we have shown that Rab17 levels must be suppressed for ERK2 to drive breast cancer 
invasiveness.  Consistently, reduced Rab17 has been shown to be associated with 
increased aggressiveness in hepatocellular carcinoma (Wang et al, 2015).  Taken together 
these studies suggest that Rab17 may oppose events that accompany the DCIS to IDC 
transition – such as the loss of cell polarity and the acquisition of invasiveness – and this 
would be likely to be mediated by controlling endosomal trafficking of pro- and/or anti-
invasive receptor cargoes.   
As there is no reason to propose that the known receptor cargoes of Rab17-regulated 
transport – such as dlgA and TfnR – would be drivers of the DCIS to IDC transition or cancer 
invasiveness, we developed an unbiased mass spectrometry (MS)-based proteomic 
approach to investigate Rab17’s interactome and the protein cargoes whose trafficking it 
influences.  To do this we combined quantitative SILAC-based proteomics with a 
biotinylation-based method to separate plasma membrane from endosomal proteins.  From 
this approach we found that Rab17 mediates its anti-invasive effects via interaction with the 
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SNARE protein Vamp8,  and that Rab17-Vamp8 influences the endosomal-plasma 
membrane distribution of a number of cargoes that might be expected to influence 
invasiveness.  Prominent amongst these is neuropilin-2 (NRP2) which moves from 
endosomes to the plasma membrane following Rab17 depletion.  We conclude by showing 
that NRP2 is required for the DCIS to IDC transition and the acquisition of invasiveness that 
is driven by depletion of Rab17-Vamp8.     
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RESULTS 
Low levels of Rab17 mRNA correlate with poor breast cancer survival 
We have previously shown that reduced Rab17 mRNA levels are associated with invasive 
migration of breast cancer cells (von Thun et al, 2012). To determine whether this 
observation is pertinent to aggressiveness of the human disease we interrogated the caBIG, 
GEO and TCGA repositories via the ‘kmplot’ analysis tool (Gyorffy et al, 2013). Consistent 
with our previous results, we found that low levels of Rab17 expression in breast tumours 
was strongly associated with poor overall patient survival (p<0.0001)  (Fig. 1A), and this was 
statistically significant in all breast cancer intrinsic subtypes (Fig. S1 A-C), with the exception 
of HER-enriched subtype (Fig. S1D). Survival of ovarian cancer patients was also 
associated with low Rab17 expression (p<0.0001) (Fig. S1E), but we were unable to 
demonstrate any correlation between Rab17 levels in lung or gastric cancers (not shown).  
 
Quantitative proteomics indicate that Rab17 controls Vamp8 levels  
We hypothesised that Rab17 may restrict invasiveness by controlling the expression or 
trafficking of proteins that are invasion suppressors.  To search for these we knocked-down 
Rab17 (Fig. S1F) and performed a SILAC-based global proteomic mass spectrometry 
analysis.  We labelled control and Rab17 knockdown MDA-MB-231 breast cancer cells with 
light and heavy SILAC amino acids respectively (forward (Fw) experiment), and with heavy 
and light amino acids respectively (reverse (Rev) experiment). We then prepared cells 
extracts, and quantified them on an LTQ-Orbitrap. MS data were analysed with the 
MaxQuant computational platform. Accurate protein quantification highlighted high 
reproducibility between Fw and Rev experiments. Despite the large number of proteins that 
were unambiguously identified and quantified, we found that only a single protein was 
significantly downregulated (in both Fw and Rev experiments) in Rab17 knockdown cells 
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and this was the v-SNARE, Vamp8 (Fig. 1B; supplementary spreadsheet 1). We confirmed 
this result by knocking-down Rab17 in MDA-MB-231 cells using either a single siRNA 
oligonucleotide or pooled siRNAs followed by Western blotting.  (Fig. 1C, D). Moreover, this 
analysis indicated that levels of Vamp3 and Vamp7 (the most closely related Vamp to 
Vamp8) were unaffected by knockdown of Rab17 (Fig.1C). Furthermore, since Rab17 
knockdown suppressed Vamp8 protein but not levels of its mRNA, we conclude that Rab17 
controls Vamp8 expression post-transcriptionally (Fig, S2A, B).   
Our previous work has identified Rab17 to be a key effector of MAP kinase signalling.  
Following suppression of ERK2 (but not ERK1), Rab17 levels are increased and this leads to 
increased invasiveness (von Thun et al, 2012).  To determine whether the ability of MAP 
kinase signalling to influence Rab17 was, by turns, capable of controlling Vamp8 levels, we 
knocked down ERK2 and measured Vamp8 levels by Western blotting.  Knockdown of 
ERK2 led to increased levels of the mRNA for Rab17 and Vamp8 protein (Fig. 1E), further 
supporting the view that Rab17 controls Vamp8 levels and suggesting that suppression of 
this v-SNARE may underlie ERK2’s ability to drive invasiveness.   
 
The Rab17-Vamp8 complex is localised to late endosomes 
We used MS-based proteomics to investigate Rab17’s interactome. We expressed GFP-
tagged Rab17 (GFP-Rab17) or GFP in MDA-MB-231 cells and immunoprecipitated these 
using GFP-trap beads.  A label-free quantification approach was then used to identify a set 
of 95 proteins that constitute the Rab17 interactome, and Vamp8 was a prominent 
component of this (Fig. 1F; supplementary spreadsheet 2). We used Western blotting to 
confirm the association between Rab17 and Vamp8 (but not Vamp7), and also found that 
Rab24 (a Rab GTPase which is closely related to Rab17) did not coimmunoprecipitate with 
Vamp8 indicating that there was a degree of specificity to the Rab17-Vamp8 interaction (Fig. 
1G).  To determine whether Vamp8 and Rab17 were able to interact directly with each other, 
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we produced the cytoplasmic region of Vamp8 (Vamp8cyto) and GST-tagged-Rab17s (both 
the wild-type and a constitutively active GTPase-deficient mutant of the protein) in E.Coli and 
purified these.  However, we were unable to demonstrate co-precipitation of purified soluble 
Vamp8cyto with glutathione bead-conjugated Rab17s (Fig. S2C)  indicating that these 
proteins either do not interact directly or interact transiently. Next, we used STRING software 
(http://string-db.org) (Szklarczyk et al, 2015) to examine known functional interactions 
between proteins of the Rab17 interactome.  In addition to the anticipated Rab protein/signal 
transduction and SNARE complex groups, we found that Rab17 associated with proteins 
related to lysosomes (Fig. S2D).  Indeed, when we annotated our Rab17 interactome to 
denote the intracellular compartmentalisation of its components, we found that 43% of 
Rab17’s interactors may be classified as late endosomal and/or lysosomal proteins (Fig. 
1H).   
GFP-Rab17 displayed significant co-localisation (Pearson’s coefficient=0.82 ± 0.089) with 
endogenous Vamp8 at vesicular structures in the perinuclear region of MDA-MB-231 cells, 
consistent with late endosomal localisation of Rab17/Vamp8 (Fig. 2A). Indeed, endogenous 
Vamp8 displayed significant colocalisation with both endogenous (Fig. 2B, C; Pearson’s 
coefficient ~ 0.6) and GFP-tagged (Fig. S3) markers of late endosomes, such as CD63 and 
Lamp1/2.  As described in Fig. 1, we observed a (50-60%) reduction in Vamp8 levels 
following Rab17 knockdown.  Correspondingly, the late endosomal distribution of Vamp8 
was disrupted by following siRNA of Rab17.  Thus the residual Vamp8 in Rab17 knockdown 
cells was distributed more generally in the central region of the cell, and its colocalisation 
with CD63-positive structures was significantly reduced (Fig. 2C, D).   
 
Rab17 and Vamp8 oppose breast cancer cell invasiveness in 3D models  
Our identification of Vamp8 as an interactor of Rab17, and the fact that Vamp8 was 
downregulated in Rab17-depleted cells, prompted us to determine whether Vamp8 
contributed to Rab17’s ability to function as a suppressor of breast cancer cell invasiveness.  
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Initially, we investigated the consequences of knocking down Rab17 or Vamp8 on the ability 
of MDA-MB-231 cells to invade into plugs of Matrigel supplemented with fibronectin. siRNA 
of Rab17 increased invasiveness of MDA-MB-231 cells.  Interestingly, siRNA of Vamp8 also 
promoted invasiveness into Matrigel plugs, consistent with the view that Vamp8 is 
functionally linked to Rab17 (Fig. 3A). These data led us to hypothesise that Rab17 and 
Vamp8-dependent trafficking might drive the transition between DCIS and IDC in the 
mammary gland, thus contributing to breast cancer progression. Experimentally, this 
transition may be modelled using the MCF10DCIS.com breast cancer cell line. 
MCF10DCIS.cells are estrogen receptor (ER)-negative premalignant mammary carcinoma 
cells which are derived from the ‘normal’ MCF10A cell line and are known to form well-
defined comedo-like DCIS structures when injected as subcutaneous or intraductal 
xenografts (Behbod et al, 2009; Miller et al, 2000).  However, with time these lesions 
spontaneously progress to invasive carcinoma characterised by disruption of their 
surrounding basement membrane, and the development of invasive outgrowth.  Elements of 
this progression may be recapitulated in 3D culture (Jedeszko et al, 2009). Since the levels 
of Vamp8 in MCF10DCIS.com cells were dependent on Rab17 expression (Fig. S4A, B), we 
used this model to study the role of Rab17 and Vamp8 in the DCIS to IDC transition.  When 
MCF10DCIS.com cells were cultured for 3 days in Matrigel they formed well-organised 
comedo-like structures which were surrounded by basement membranes evidenced by 
immunofluorescence staining for the basolateral marker β4 integrin and the basement 
membrane component laminin-V (Fig. 3B). We quantitatively assessed the shape of these 
organoids and found that MCF10DCIS.com cells formed structures that were roughly 
spherical – as reflected by a low deviation from circularity of a cross sectional focal plane 
(Fig. 3C). However, when either Rab17 or Vamp8 were knocked-down in MCF10DCIS.com 
cells (using either a SMARTPool or individual siRNA sequences), structures with a high 
degree of sphericity were able to initially form (not shown), but their symmetry became 
significantly disrupted after 3 days of culture in Matrigel (Fig. 3C). Consistently, 
immunofluorescence staining for β4 integrin and laminin-V indicated that siRNA of Rab17 or 
Jo
ur
na
l o
f C
el
l S
ci
en
ce
 •
 A
dv
an
ce
 a
rt
ic
le
  
Vamp8 drove substantial disruption of the basement membrane surrounding the comedo-like 
structure allowing MCF10DCIS.com cells to migrate out of the organoid (Fig. 3B). 
Furthermore, the ability of siRNAs targeting Rab17 or Vamp8 to disrupt the sphericity of 
MCF10DCIS.com organoids was completely reversed by expression of siRNA resistant 
(rescue) versions of GFP-Rab17 and GFP-Vamp8 respectively (Fig. 3C; Fig. S4C, D).  
Finally, combined knockdown of Rab17 and Vamp8 did not increase the disruption of 
sphericity evoked by individual siRNA of these proteins, consistent with Rab17 and Vamp8 
operating on the same signalling axis (Fig. S4E). Taken together these data are consistent 
with a role for Vamp8 in mediating Rab17’s anti-invasive functions, and that this is evident in 
a 3D model of the DCIS to IDC transition.   
 
Vamp8 levels are associated with tumour grade in breast cancer 
Our data indicating the likelihood that Rab17 exerts its anti-invasive effects by maintaining 
Vamp8 levels, prompted us to investigate the relationship between Vamp8 and invasive 
pathology in breast cancer.  In the normal mouse mammary gland, Vamp8 appeared to be 
associated with the luminal face of the ductal epithelium (Fig. 4A).  Expression of the 
polyoma middle-T antigen (PyMT) under control of the MMTV mammary-specific promoter 
(MMTV-PyMT), results in formation of tumours in the mouse breast with high penetrance.  
MMTV-PyMT tumours have a gene expression profile similar to human luminal B cancers 
(Herschkowitz et al, 2007), and most of these progress from DCIS-like structures to IDC in a 
similar fashion to the human disease.  We, therefore, looked at the distribution of Vamp8 in a 
number of tumours from MMTV-PyMT mice and compared this with their histopathology.  
We found that Vamp8 levels were high in the less advanced MMTV-PyMT tumours that 
displayed DCIS-like pathology, whereas in more invasive tumours with IDC-like 
characteristics Vamp8 levels were low (Fig. 4A).  We then deployed a large tissue 
microarray (TMA) containing 542 human breast tumours to test whether this inverse 
Jo
ur
na
l o
f C
el
l S
ci
en
ce
 •
 A
dv
an
ce
 a
rt
ic
le
  
relationship between Vamp8 levels and features of tumour aggressiveness may be observed 
in human breast cancer.  Furthermore, because some Vamp8 immunoreactivity observed in 
breast tumours appeared to be diffusely distributed within the cells, we scored our TMA only 
for Vamp8 that was localised membranous structures that were either in the cell periphery or 
within the cell. There was a highly significant inverse correlation between membranous 
Vamp8 staining and tumour grade.  Indeed, the majority of low grade (grade I) tumours  had 
high levels of Vamp8, whereas most high grade (grade III) tumours displayed less intense 
membranous Vamp8 staining (Table 1; Fig. 4B).   Moreover, Vamp8 levels were significantly 
correlated with breast cancer molecular subtype in a way that was consistent with tumour 
grade.  For example, Vamp8 levels were low in the majority of the highly aggressive ER-
negative subtype, whereas a minority of ER-positive tumours had high Vamp8 levels (Table 
1).  These data indicate that loss of Vamp8 occurs as murine mammary tumours progress 
from DCIS to IDC and that Vamp8 levels are maintained in less aggressive luminal A and 
low grade human tumours in comparison to more aggressive cancers, which is consistent 
with an anti-invasive role for Rab17/Vamp8.  
 
A SILAC-based mass spectrometry screen reveals NRP2 to be a Rab17 cargo 
We hypothesised that Rab17/Vamp8-regulated trafficking pathways might suppress invasion 
by either reducing delivery of pro-invasive receptors to the plasma membrane, or by 
increasing recycling of anti-invasive cargoes.  We designed a strategy (schematically 
summarised in Fig. 5A) which allowed us to identify alterations to receptor distribution 
between endosomes and the plasma membrane in an unbiased way.  To do this we 
combined SILAC-based MS proteomics with compartment-specific protein biotinylation 
approaches.  As before, we labelled control and Rab17 knockdown MDA-MB-231 cells with 
light and heavy SILAC amino acids (Fw experiment), and with heavy and light amino acids 
respectively (Rev experiment).  We then surface-labelled these cells at 4ºC with membrane 
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impermeant sulpho-NHS-SS-Biotin and isolated the fraction of plasma membrane proteins 
using streptavidin affinity chromatography – this complement of proteins we termed the 
‘surface proteome’.  In a separate set of culture dishes, we warmed SILAC-labelled surface-
biotinylated cells to 37ºC for 20 min to allow surface-labelled receptors to distribute between 
endosomes and the plasma membrane.  As the sulpho-NHS-SS-Biotin reagent contains a 
disulphide linker that may be cleaved by reducing agents, we were able to remove biotin 
from receptors remaining at the cell surface by treatment with the membrane impermeant 
reducing agent, MesNa.   The remaining endosomally-localised biotinylated receptors were 
then isolated using streptavidin beads, and this fraction of proteins we termed the 
‘internalised proteome’.  The surface and internalised proteome from the Fw and Rev 
experiments were then analysed by high resolution mass spectrometry.  This provided 
unambiguous identification of 1640 surface proteome and 2272 internalised proteome 
components and, as expected, the majority of protein isolated using this surface biotinylation 
approach were membrane and/or membrane-associated proteins (not shown). We then 
looked for proteins whose relative abundance between surface and endosomal 
compartments was reproducibly (in the Fw and Rev experiments) influenced by Rab17 
knockdown.  We categorised these according to whether their abundance was co-ordinately 
or differentially regulated at the cell surface and the endosome by Rab17 knockdown.  The 
largest category constituted those proteins whose abundance was co-ordinately increased in 
the surface proteome and the internalised proteome by Rab17 knockdown (upper right 
quadrant in Fig. 5B; supplementary spreadsheet 3). Prominent amongst these were the pro-
invasive transmembrane matrix metalloprotease MT1-MMP and the receptor tyrosine kinase, 
EGFR1, indicating that degradation of these receptors may be suppressed following Rab17 
knockdown.  
The purpose of this study was to identify novel cargoes of Rab17 - i.e. proteins that were 
distributed differently between the cell surface and endosomes following siRNA of Rab17.  
We, therefore, focussed our attention on those hits whose abundance moved in opposite 
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directions in the surface proteome and internalised proteome following Rab17 knockdown 
(upper left quadrant in Fig. 5B; supplementary spreadsheet 3).  Interestingly, this analysis 
revealed neuropilin-2 (NRP2), which is a co-receptor for semaphorins and vascular 
endothelial growth factor (VEGF), to be the protein whose surface expression was most 
significantly increased (1.5 fold) at the cell surface and reduced (1.2 fold) in the internalised 
proteome when Rab17 was silenced (Fig. 5B). Western blotting confirmed that siRNA of 
Rab17 increased the quantity of NRP2 at the cell surface and decreased the endosomal 
pool of NRP2, whilst its total cellular content remained unchanged (Fig. 5C).  Furthermore, 
we found that knockdown of Vamp8 evoked similar alterations to NRP2’s plasma 
membrane/endosomal distribution to that elicited by siRNA of Rab17 (Fig. 5C).    
 
Trafficking of NRP2-positive vesicles is altered by suppression of Rab17/Vamp8  
Our proteomic analysis indicated that NRP2 redistributes from endosomes to the cell surface 
following Rab17 knockdown, suggesting that the endosomal trafficking of this receptor is 
regulated by Rab17/Vamp8. To visualise the trafficking of NRP2, we transfected MDA-MB-
231 cells with GFP-tagged NRP2 in combination with the late endosomal marker mCherry-
Lamp1 and performed fluorescence live cell imaging followed by quantitative vesicle 
tracking. GFP-NRP2 was localised to large Lamp1-positive late endosomes which were 
located primarily in the perinuclear region, and quantitative analysis indicated that less than 
40% of NRP2-positive structures occupied an area of less than 2 μm2 (Fig. 6A, B).  
Moreover, NRP2-positive vesicles had low motility and many of the larger vesicles were 
largely stationary during the course of the movies. By contrast, following siRNA of either 
Rab17 or Vamp8, the number of smaller NRP2-positive vesicles increased dramatically 
(>70% of structures being less than 2μm2), and quantitative tracking analysis indicated that 
the speed of their movement significantly increased (Fig. 6A, B). Moreover, the population of 
smaller vesicles that was evoked by knockdown of Rab17 or Vamp8 still overlapped 
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substantially with Lamp1-containing structures. Taken together, these data indicate that 
Rab17 and Vamp8 act to restrict the movement of a late endosomal/lysosomal compartment 
in which NRP2 is concentrated and, following suppression of either of these two trafficking 
regulators, NRP2 is localised to a population of smaller and more motile late endosomes.  
This observation is consistent with increased mobilisation of NRP2-containing late 
endosomes from the perinuclear region to more peripheral cellular locations and to the 
plasma membrane. 
 
NRP2 is required for invasiveness evoked by suppression of Rab17/Vamp8  
Our MS analysis indicated that NRP2 redistributes from endosomes to the cell surface 
following Rab17 knockdown suggesting that this receptor is a pro-invasive cargo whose 
recycling is opposed by Rab17/Vamp8.  We, therefore, provoked breast cancer cell 
invasiveness by knocking-down Rab17 or Vamp8 and tested the requirement for NRP2 in 
this. Knockdown of NRP2 had no effect on the ability of MCF10DCIS.com cells to assemble 
basement membrane-like structures and to form spherical acini when grown in 3D Matrigel 
cultures (Fig. 7A, B).  However, siRNA of NRP2 (using either a SMARTPool siRNA or an 
individual siRNA sequence) opposed the ability of Rab17 and Vamp8 knockdown to drive 
basement membrane degradation and to disrupt acinar sphericity (Fig. 7A, B).   Consistently, 
we found that siRNA of NRP2 completely opposed the ability of both Rab17 and Vamp8 
knockdown to drive invasion of MDA-MB-231 cells into Matrigel plugs (Fig. 7C).  
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DISCUSSION 
The available database information concerning Rab17 and its interactors is insufficient to 
infer potential effectors and pathways through which this GTPase acts to suppress cancer 
invasiveness and progression.   We, therefore, determined Rab17’s interactome and its 
influence on the cellular proteome in an unbiased way.  The use of high accuracy MS-based 
approaches has enabled us to do this, and to show that Rab17 has a close physical and 
functional relationship with the SNARE protein, Vamp8.   Rab GTPases are known to recruit 
specific effector proteins that bind to SNAREs giving specificity to vesicle fusion (Angers & 
Merz, 2011).   Nevertheless, to our knowledge, our study is the first to provide an indication 
that the stability and cellular levels of a SNARE protein may be controlled by a Rab GTPase.  
Moreover, because Vamp8 is the only component of the proteome that is significantly altered 
following Rab17 knockdown, the relationship between this GTPase and Vamp8 stability is 
likely to be highly selective.  Our mass spectrometric and immunofluorescence data indicate 
that Vamp8 is localised primarily to late endosomes, and that its recruitment to this 
compartment is strongly dependent on Rab17.  Thus, these data are consistent with a view 
that Rab17 acts primarily to recruit Vamp8 to late endosomes and, when Rab17 levels are 
low, Vamp8 becomes mislocalised and is subsequently degraded.  We have found that 
neither proteosomal nor lysosomal mechanisms are responsible for degradation of 
mislocalised Vamp8 (not shown).  However, a report that caspases regulate Vamp8 
expression and function in dendritic cells indicates the possibility that Rab17 could protect 
Vamp8 from caspase cleavage by localising it to late endosomes (Ho et al, 2009). Increased 
Vamp8 is primarily thought to promote homotypic fusion of either early or late endosomes 
(Antonin et al, 2000; Pryor et al, 2004).  Endosomal compartments are constantly engaged 
in homotypic fusion and fission, and the relative rates at which these two processes occur 
dictate the size and identity these compartments. Our observation that NRP2-containing late 
endosomes are large when Vamp8 levels are high is consistent with a role for this v-SNARE 
in homotypic fusion of these compartments. Thus, activation of ERK2 which leads to 
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downregulation of Rab17 and, in turn, reduced Vamp8 levels might be expected to shift the 
homotypic fusion/fission balance of late endosomes in favour of fission to promote 
mobilisation of NRP2-containing late endosomes to the plasma membrane to drive invasion.   
Rab17 expression has been known for a number of years to be associated with 
establishment of a polarised epithelial phenotype (Hunziker & Peters, 1998; Lutcke et al, 
1993; Zacchi et al, 1998), and its downregulation is linked to loss of epithelial polarity (Lutcke 
et al, 1993).  Our observations that downregulation of Rab17 accompanies events such as 
the DCIS to IDC transition and the disruption of acinar morphology (including breaching of 
the basement membrane) are consistent with a role for Rab17 in maintaining epithelial 
morphology and opposing epithelial to mesenchymal transition or EMT.   Thus it is probable 
that cargoes trafficked by Rab17 are involved in maintenance of epithelial polarity and, 
consistently, Rab17 has been shown to control trafficking events, such as transcytosis, that 
are peculiar to polarised epithelia (Hunziker & Peters, 1998; Zacchi et al, 1998).  Vamp8 has 
been functionally linked to transcytosis (Pocard et al, 2007).  Indeed, most evidence 
indicates that this SNARE, like Rab17, plays an important role in controlling trafficking 
events that support maintenance of epithelial polarity.  In epithelial cells, Vamp8 is 
responsible for sorting apical cargoes, such as dipeptidyl peptidase IV (DPPIV), to the apical 
plasma membrane  (Pocard et al, 2007).  Many tumour cells retain some, but not all, of the 
characteristics of a polarised epithelium.  For instance, comedo-forming tumour cells, such 
as MCF10DCIS.com, have a basement membrane which corresponds to a basolateral 
region, but do not have a well-defined apical domain.  Thus, it is interesting to speculate 
about the role played by the transcytotic machinery in partially polarised comedo-like 
organoids and other less polarised cells.  One possibility is that in the absence of an apical 
domain (such as is encountered in MCF10DCIS.com cells), proteins such as Rab17 and 
Vamp8 might still function to move receptors that could potentially disturb basement 
membrane integrity away from the plasma membrane and into other compartments.  
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Therefore, we developed an unbiased approach to identify the receptors whose distribution 
between the plasma membrane and endosomes was altered following loss of Rab17.   
Characterisation of the endomembrane proteome is complicated by the fact that it is difficult, 
if not impossible, to obtain purified endosomal fractions that are uncontaminated by 
components from other cellular subcompartments. To overcome this, we have used a biotin-
labelling approach which allows enrichment of internalised protein cargo, and combined this 
with a quantitative SILAC method designed to highlight consistent changes in plasma 
membrane/endosomal distribution evoked in response to a defined pro-invasive stimulus. By 
focussing on these changes, interference from proteins that are non-specifically associated 
with plasma membrane and/or endosomal isolates is minimised. The receptor whose 
distribution is most significantly altered by Rab17 knockdown is NRP2.  The neuropilins are 
well-established to contribute to axonal guidance and angiogenesis (Raimondi & Ruhrberg, 
2013), however the roles played by these receptors in epithelial cells has received less 
attention.  Neuropilins and the receptors with which they collaborate, such as VEGF 
receptors, are generally thought to be restricted to the apical/luminal domains of epithelial 
ducts to reduce their exposure to growth factor ligands that are abundant in the interstitium 
(Wild et al, 2012).  Consistently, upregulation and/or mislocalisation of NRP1 and NRP2 to 
the basolateral region correlates with invasiveness and poor prognosis in a number of 
tumour types (Wild et al, 2012).  Our data indicate that Rab17/Vamp8 promotes removal of 
NRP2, and other potentially proinvasive receptors (such as MT1-MMP), from the basolateral 
membrane so that they can be routed to cellular locales where they will not disrupt basement 
membrane integrity.  Thus, in normal epithelia the role of Rab17/Vamp8 might be to 
transcytose these receptors to the apical domain, but in partially transformed comedo-like 
tumours Rab17/Vamp8 strives to oppose the transition to invasive carcinoma by actively 
retaining NRP2 safely within the late endosomal system. Thus, Rab17/Vamp8-dependent 
sequestration of NRP2 within the endosomes of tumour cells likely represents a remnant of 
the transcytotic system which still acts to suppress basement membrane disruption and 
Jo
ur
na
l o
f C
el
l S
ci
en
ce
 •
 A
dv
an
ce
 a
rt
ic
le
  
DCIS to IDC transition.  Suppression of Rab17 levels by the activation of ERK2 signalling, 
likely represents a key event in loss of the last vestiges of epithelial polarity which allows 
tumours to invade and metastasise.  Our use of novel MS proteomics to identify NRP2 as a 
cargo of the Rab17/Vamp8 pathway indicates that loss of control over trafficking of this 
receptor is a key event in the DCIS to IDC transition. 
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MATERIALS AND METHODS 
Cell culture and transfection 
MDA-MB-231 cells were cultured as described previously (von Thun et al, 2012). MCF10A 
DCIS.com cells were kindly provided by Prof. Philippe Chavrier (Institut Curie, Paris, France) 
and were cultured and transfected as described previously (Macpherson et al, 2014). Rab17 
siRNA oligos were SMARTpool, #1 5’-GAAGUGGCUCCGUGGGUAA-3’ or #2 5’-
ACGCUGCGCUUCUGGUGUA-3’ (Dharmacon). Vamp8 and NRP2 siRNA oligos were 
SMARTpool (Dharmacon, CA, USA). EGFP-C1-Rab17 was a gift from Jeremy Simpson 
(University College, Ireland). CD63- and Rab11-GFP constructs were as described 
previously (Macpherson et al, 2014). GFP-NRP2 in pCMV6-AC-GFP was from Amsbio 
(MG223943), and GFP-Vamp8 was a gift from Thierry Galli (Addgene plasmid #42311 
(Paumet et al, 2000)).  Cells were transfected using the Nucleofector system as described 
previously (Macpherson et al, 2014). SILAC-labeled MDA-MB-231 cells were obtained by 
culturing in SILAC-DMEM lacking arginine and lysine (Life Technologies, CA, USA) 
supplemented with L-arginine and L-lysine (SILAC light) (Sigma-Aldrich, St. Louis, MO, 
USA) or 13C615N4 L-arginine  and 13C615N2 L-lysine (SILAC heavy; Cambridge Isotope 
Laboratories, Tewksbury, MA, USA).  3D culture of MCF10DCIS.com cells and inverted 
invasion assays were performed as described previously (Macpherson et al, 2014). 
 
qRT-PCR  and  Western blotting 
Primers for GAPDH, Rab17 and Vamp8 were obtained from Qiagen (cat# QT01192646, 
QT00009590 and QT00086639 respectively) NRP2 primers were ordered from Thermo 
Fisher Scientific (Wittmann et al, 2015) and qRT-PCR experiments were performed 
conducted as described previously (von Thun et al, 2012). Antibodies recognising Vamp8 
(Synaptic systems, Göttingen, Germany), Vamp7 and Vamp3 were a gift from Andrew 
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Peden (University of Sheffield, UK). Antibodies against β tubulin (Sigma-Aldrich, Dorset, 
England), GFP (Abcam, Cambrige, UK), laminin V (Millipore, Darmstadt, Germany), β4 
integrin (BD Biosciences, Becton, Dickinson and Company), NRP2 (R&D, Abingdon, UK), 
and ERK1/2 (Santa Cruz K-23), were used for Western blotting. 
 
Recombinant protein expression, pulldown and site directed mutagenesis 
Vamp8 amino acids 1-74 was sub-cloned into pGEX-6P-1 from GFP-Vamp8 plasmid using 
EcoR1 and Xho1 restriction sites. GST-Vamp8cyto and GST-Rab17 were transformed into 
OneShot® BL21(DE3) E.coli (Invitrogen) grown at 37 ºC for 6 hours and then induced with 
IPTG for 16 hours. Bacteria were lysed by sonication in PBS and proteins purified using 
glutathione-sepharose beads (GE Healthcare). Vamp8 was subsequently cut from the beads 
with PreScission protease (GE Healthcare) 1.6 units per 10 µl cleavage buffer (50 mM Tris-
HCL pH 6.8, 150 mM NaCl, 1 mM EDTA, 0.01% Triton X-100, 1 mM DTT). The resulting 
protein was quantified via NuPAGE Tris-acetate gel and equal quantities of Vamp8 and 
Rab17 were incubated for 16 hours at 4ºC. The beads were then washed twice with PBS 
and the input and beads run on NuPAGE Tris-acetate gel and whole protein levels analysed 
with InstantBlueTM Coomassie stain (Expedeon). 
Site directed mutagenesis was carried out using QuikChange Lightning kit (Agilent) to create 
GST-Rab17Q77L (forward 5’-TGTGGTACTTCTTCCAGGCCAGCTGTGTCC-3’ and reverse 
5’-GGACACAGCTGGCCTGGAGAAGTACCACA-3’) and the two rescue vectors to si-#1 
GFP-Rab17 T81C_C84G_C87A_G90T forward 5’-
GCCAAGCTGGACTTACCAACTGACCCGCTTCCCAGGAGAACCAG-3’ 
Reverse 5’-CTGGTTCTCCTGGGAAGCGGGTCAGTTGGTAAGTCCAGCTTGGC-3’, and 
GFP-Vamp8 to si-#2 c234t_t237g_c240a_c243t forward 5’- 
CTGGTGGAAGAACGTGAAGATGATTGTTCTGATATGTGTGATTGTTTTTATCATCATCCT
CTTC-3’ reverse 5’- 
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GAAGAGGATGATGATAAAAACAATCACACATATCAGAACAATCATCTTCACGTTCTTCCA
CCAG-3’. 
 
Surface and internalised proteome analysis 
SILAC-labelled MDA-MB-231 cells were transfected with siRNAs targeting Rab17 or a non-
targeting control and plated into 10cm plastic dishes.  48hr later cells were surface-
biotinylated  by incubation with 0.2 mM sulpho-NHS-SS-Biotin (Thermo Fisher Scientific, 
Paisley, UK) in PBS at 4 °C for 1 hr. To study the internalised proteome, surface-biotinylated 
cells were transferred to SILAC-DMEM (Gibco, Life technologies) at 37 °C for 20 min to 
allow internalisation of labelled protein, and then biotin remaining at the cell surface was 
removed by incubation with a cell impermeant reducing agent (MesNa) 20mM (Fluka Sigma-
Aldrich, Dorset, England) in Tris-buffered saline (pH8.6) for 50 min at 4 °C.  Remaining 
MesNa was quenched by incubation with iodoacetamide (IAA; 20mM Sigma-Aldrich ). Cells 
were lysed in 200 mM NaCl, 75 mM Tris, 15 mM NaF, 1.5 mM Na3VO4, 7.5 mM EGTA, 
1.5% Triton X-100, 0.75% Igepal CA-630, 0.5 mg/ml leupeptin (Melford, Suffolk, UK), 0.25 
mg/ml aprotinin (Sigma), and 5 mM 4-(2-Aminoethyl)benzynesulphonyl fluoride (AEBSF) 
(Melford) and lysates cleared by centrifugation at 10,000 × g for 10 min at 4 °C. The 
supernatants from the heavy and light SILAC labelled cells were then mixed and biotinylated 
proteins were captured by incubation with streptavidin-agarose beads (UPSTATE, Millipore) 
for 1 h at 4 °C with constant rotation. Following extensive washing, specifically-associated 
proteins were eluted by treatment with cleavage with 0.1 M DTT (0.1M) in a Tris buffer (pH 
7.5).   
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MS analysis 
Proteins were separated on 4-12% gradient NuPAGE Novex Bis-Tris gel (Life 
Technologies), visualised by staining of the gels with Comassie blue and digested in-gel (8 
gel slices were cut for the Surface proteome/Internalised proteome; 5 gel slices for Rab17 
IP) using trypsin (Shevchenko et al, 2006) and desalted as described previously (Rappsilber 
et al, 2007). For the proteome of cells silenced for Rab17, proteins were trypsin digested 
using the filter-aid sample preparation (FASP) method and 50 µg of peptides separated by 
strong anion exchange chromatography on StageTip as previously described (Wisniewski, J. 
R. and Mann M. J Proteome Res 8:5674; 2009). Digested peptides were loaded onto an 
EASY-nLC connected online to an LTQ-Orbitrap Elite mass spectrometer (Thermo-Fisher 
Scientific). Peptides were separated using a 20 cm fused silica emitter (New Objective) 
packed in house with reversed-phase Reprosil Pur Basic 1.9 µm (Dr. Maisch GmbH) and 
eluted with a flow of 200 nl/min from 5% to 20-30% of buffer containing 80% ACN in 0.5% 
acetic acid, in a 90 min (190 min gradient for the proteome of si-Rab17 cells) linear gradient. 
The full scan MS spectra were acquired at a resolution of 120,000 at m/z 400. The top 10 
most intense ions were sequentially isolated for fragmentation using high-energy collision 
dissociation, and recorded at resolution of 15,000. Data were acquired with Xcalibur 
software (Thermo-Fisher Scientific). 
 
MS data analysis 
The MS files were processed with the MaxQuant software (Cox & Mann, 2008) version 
1.3.7.4 (proteome) and 1.3.8.2 (internalised proteome and interactome) and searched with 
the Andromeda search engine (Cox et al, 2011) against the human UniProt database 
(release-2012 01, 88,847 entries). The common reverse and contaminant hits (as defined in 
MaxQuant output) were removed. Only protein groups identified with at least one uniquely 
assigned peptide were used for the analysis. For the SILAC experiments, the SILAC ratios 
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between light and heavy peptides were calculated by MaxQuant. Protein groups were 
considered reproducibly quantified if identified and quantified in forward and reverse 
experiment. For label-free quantification proteins were quantified according to the label-free 
quantification algorithm available in MaxQuant (Cox et al, 2014). 
Surface proteome and internalised proteome (SILAC): From the filtered list of quantified 
proteins, hits with opposite regulation (= opposite sign when SILAC ratio expressed as log2) 
in the two experiments were excluded. To identify differentially trafficked proteins upon 
Rab17 knockdown, proteins belonging to the 1st or 3rd of the SILAC ratio distribution of the 
forward and reverse experiment were considered. This statistical approach allowed us to 
select proteins with small but reproducible (in both forward and reverse SILAC experiments) 
changes in localization. 
Rab17 knockdown proteome (SILAC): For forward and reverse experiment, protein groups 
with significant SILAC ratio were determined according to the Significance B (Cox et al, 
2011), using 5% as FDR. The Significance B identifies outliers based on the standard 
deviation of the protein SILAC ratio of the main distribution and the protein abundance 
(Intensity measured at the MS). The significance B was chosen because, as typically shown 
for SILAC datasets (Cox et al, 2011), the distribution of the logarithmic SILAC ratios was 
dependent on the protein intensity, where the spread of nonregulated proteins was higher for 
low compared to high abundant proteins. For this reason, for low abundant proteins to be 
significant a higher deviation from the SILAC ratio main distribution is required. Conversely, 
for high abundant proteins a higher deviation is required. 
Interactome (label-free): Three independent replicates were generated per condition (Ctl and 
Rab17 IP) and significantly enriched proteins were selected using a Welsh test-based 
analysis (5% FDR). The Welsh test is particularly suitable for this kind of samples, IP where 
Ctl and Rab17 samples could recover different number and amount of interacting proteins, 
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because this test is designed for studies where the two samples have unequal variances and 
unequal sample sizes. 
 
Immunofluorescence and immunohistochemistry 
Antibodies against CD63 (PeliCluster M1544), Lamp2 (BD Pharmingen 555803), FITC 
(Southern Biotech 1031-02) and phalloidin-Alexa 546 (Thermo Fisher Scientific, Paisley, UK) 
were used for immunofluorescence. Cells were stained and imaged using either 64x or 60x 
objective with an inverted confocal microscope (Fluoview FV1000; Olympus). To quantify 
localisation, the confocal images were analysed using colocalisation2 plugin in ImageJ and 
plotting the Pearson’s coefficient which indicates positively correlated pixels. 
Immunohistochemical staining was performed as described previously (Dozynkiewicz et al, 
2012; Macpherson et al, 2014) – the antibody recognising Vamp8 was from 
Synapticsystems (Göttingen, Germany).  
 
Live cell imaging 
Cells were imaged using a 60x objective and an inverted confocal microscope (Fluoview 
FV1000; Olympus). Movies were captured with 0.85 sec frame intervals over a period of 
2.85 min. Tracking of GFP-NRP2 vesicles was performed using Trackmate plugin (Tinevez 
et al, 2016) and size data was collected manually both using ImageJ software. 
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Figure 1. Rab17 is a key regulator and interactor of the endosomal v-SNARE, Vamp8  
(A) Kaplan-Meier plot showing influence of Rab17 expression on overall survival in breast 
cancer. The red and black lines represent patients with Rab17 expression above and below 
the median respectively. n=1778 patients (low Rab17); n=1776 patients (high Rab17).  Log 
Rank test; p=1.2 X10-11  
(B) MDA-MB-231 cells which were SILAC-labelled with heavy and light amino acids were 
transfected with non-targeting si-RNA (si-Con) or an si-RNA targeting Rab17 (si-Rab17) 
respectively (forward (Fw) experiment). For the reverse (Rev) experiment these labelling 
conditions were swapped.  Scatter plot indicates the SILAC ratio si-Rab17/si-Control (Log2 
scale) of each protein obtained for Fw versus Rev experiment for the whole cell proteome. 
Blue dotted lines indicate the regions encompassing significantly regulated proteins  
(Significance B statistic test, False discovery rate of 5%, Perseus software) 
(C-E) MDA-MB-231 cells were transfected with siRNAs targeting Rab17 (SMARTPool or 
individual oligo Rab17#1), Vamp8 (SMARTPool (SP)), ERK2 or non-targeting controls (si-
Con#1 and si-Con#2). Vamp8, Vamp7, Vamp3 and ERK expression levels were then 
determined by Western blotting. In (E) Rab17 expression was determined using qPCR.   
(F) MDA-MB-231 cells were transfected with GFP or GFP-Rab17.  GFP-tagged proteins 
were isolated using GFP-Trap_A agarose beads (Chromotek, Planegg, Alemania). Proteins 
eluted from the beads were resolved by SDS-PAGE, stained with Comassie blue 
(Expedeon, Cambrige, UK) and in-gel digested for MS analysis. Statistical test of differences 
between means (Welch t-test) was performed to show the most differentially expressed 
proteins among three independent experimental replicates. The red dotted line indicates the 
significance threshold. Blue dots denote the 95 significant interactors identified.  
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(G) MDA-MB-231 cells were transfected with GFP, GFP-Rab17 or GFP-Rab24. GFP-tagged 
proteins were isolated as for (A) and immunoprecipitates were analysed by Western blotting 
with antibodies recognising GFP, Vamp8 or Vamp7.  
(H) Zoom of plot in Fig. 1F showing the identity (Gene name) of late endosomal-lysosomal 
associated proteins (red dots) in the Rab17 interactome.  43% of the members of Rab17’s 
interactome belong to lysosomal/late endosomal categories and are annotated according to 
(Chapel et al, 2013). 
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Figure 2. Rab17 and Vamp8 colocalise at late endosomal membranes 
(A) MDA-MB-231 cells were transfected with GFP or GFP-Rab17 (green signal), fixed and 
endogenous Vamp8 was then visualised using immunofluorescence (red signal). Pearson’s  
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coefficients were determined using the Colocalization Colormap Image J plugin and are 
depicted both as a pseudocolour scale and graphically.  Mean ± SEM, number of cells=18 
(GFP), 22 (GFP-Rab17). *** p<0.001; U-Mann Whitney. Bar: 10 µm. 
(B-D ) MDA-MB-231 cells were transfected with siRNAs targeting Rab17 (si-Rab17) or a 
non-targeting control (si-Con).  Following this, cells were fixed and stained for endogenous 
Vamp8 (red) and either CD63 (green) or Lamp2 (green).  The nuclei were counterstained 
with DAPI (blue).  Dotted squares indicate the zoomed regions.  Bar: 10 µm.  Pearson’s 
coefficients were determined as for (A), ** p<0.01; U-Mann Whitney. 
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Figure 3. Rab17 and Vamp8 oppose breast cancer cell invasiveness 
(A) MDA-MB-231 cells were transfected with siRNAs targeting Rab17 (si-Rab17), Vamp8 
(si-Vamp8) or a non-targeting control (si-Con).  Invasiveness into fibronectin-supplemented 
(25μg/ml) Matrigel (Thermo-Fisher) was determined using an inverted invasion assay. 
Invading cells were stained with Calcein-AM (Molecular Probes, Thermo-Fisher), and 
visualised by confocal microscopy.  Serial optical sections were captured at 15µm intervals, 
and are presented as a sequence in which the individual optical sections are placed 
alongside one another with increasing depth from left to right as indicated.  Migration was 
quantitated by measuring the fluorescence intensity of cells penetrating the Matrigel to 
depths of 45µm and greater, and expressing this as a percentage of the total fluorescence 
intensity of all cells within the plug. Values are mean ± SEM. n=12 measurements from three 
independent experiments. Kruskal Wallis (p<0.0001) and Dunn’s test for the multiple 
comparisons were performed (*p<0.05; ***p<0.001).  
(B, C) MCF10DCIS.com cells were transfected with siRNAs targeting Rab17 (si-Rab17 
(SMARTPool) or individual siRNA sequences Rab17#1 or Rab17#2), Vamp8 (si-Vamp8 
(SMARTPool) or individual siRNA sequences Vamp8#1, Vamp8#2, or Vamp8#3) or a non-
targeting control (si-Con), in combination with plasmids encoding siRNA-resistant forms of 
GFP-Rab17 (Rab17-rescue) or GFP-Vamp8 (Vamp8-rescue) as indicated.  Cells were 
plated into Matrigel and cultured for 3 days, following which cells were fixed and laminin V 
and β4 integrin visualised by immunofluorescence (B; green signal).  The actin cytoskeleton 
(red signal) and nuclei (blue signal) were visualized with phalloidin–Alexa-Fluor-546 and 
DAPI staining respectively (B). Bar in (B), 10 μm.  In (C), acini were visualised using phase 
contrast microscopy. Circularity was determined by measuring the ratio between the width 
and length of each acini. Values are mean ± SEM, n values in (C) from left to right are: n=88 
(Con), n=160 (Rab17#1), n=130 (Rab17#2), n=243 (NT), n=293 (Vamp8#1), n=222 
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(Vamp8#2), n=220 (Vamp8#3), n=168 (Con), n=174 (Rab17), n=201 (Vamp8), n=63 (Con), 
n=51 (Rab17), n=39 (Vamp8), n=177 (Con), n=253 (Rab17#1), n=270 (Rab17#1+ Rab17-
rescue), n=173 (Con), n=174 (Vamp8#2), and n=176 (Vamp8#2+ Vamp8-rescue).  Bar in 
(C), 100 µm.  Kruskal Wallis and Dunn’s test for the multiple comparisons were performed 
(***p<0.001, **p<0.01, *p<0.05). 
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Figure 4. Low Vamp8 levels are associated with high tumour grade in breast cancer 
Vamp8 (brown staining) was visualised in paraffin-embedded sections of normal mammary 
ducts and mammary gland tumours from MMTV-PyMT mice (A) and in a human breast 
cancer TMA (B) using immunohostochemistry. Squares indicate zoomed regions. Scale 
bars, 25 µm (A); 100μm (B).  In (A) the tumours depicted are from the intra epithelial 
neoplasm or DCIS (centre panels), and the invasive ductal carcinoma (right panels) stages 
of the disease.  In (B) representative examples of a low grade (Grade I) tumour with intense 
Vamp8 staining (left panels) and a high grade (Grade III) tumour with less-intense Vamp8 
staining (right panels) are displayed.   
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Figure 5.  SILAC-based mass spectrometry screen reveals NRP2 to be Rab17 cargo 
(A) Workflow of the SILAC based Mass Spectrometric approaches used for the comparative 
analysis of biotin label surface (surface proteome) and internalised (internalised proteome) 
proteins in SILAC-labelled MDA-MB-231 cells. This experiment was performed in a Forward 
(as indicated in this diagram) and Reverse configuration in parallel.  
(B) Scatter plot showing the SILAC ratio si-Rab17/si-Control (logarithmic scale) for each 
significantly regulated protein (grey dots). Upper-right and lower-left quadrant show proteins 
which are respectively up- or down-regulated in both the cell surface and internalised 
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proteome fractions.  The upper-left and lower-right quadrants display proteins that are 
regulated in opposite directions in the cell surface and internalised proteome fractions as 
indicated.   n=2 SILAC experiments. Significance A statistic test, False Discovery Rate of 5 
%, Perseus software.  
(C) MDA-MB-231 cells were transfected with siRNAs targeting Rab17, Vamp8 or a non-
targeting control (Con).  Cell surface and internalised proteome fractions were prepared as 
indicated in (A) and the presence of NRP2 in these was determined using Western blotting.  
The cellular NRP2, Vamp8 and β-tubulin levels were also determined (input).   
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Figure 6.  NRP2 is relocated to a population of small motile transport vesicles 
following Rab17 or Vamp8 knockdown 
MDA-MB-231 cells were transfected with GFP-tagged NRP2 and mCherry-tagged Lamp1 in 
combination with siRNAs targeting Rab17 (si-Rab17), Vamp8 (si-Vamp8) or a non-targetting 
control (si-Con).  Transfected cells were imaged by time-lapse fluorescence confocal 
microscopy.  Movies were captured with 0.85 sec frame intervals over a period of 2.85 min. 
Stills were extracted from supplementary movies 1 – 3, and GFP-NRP2 (green) and 
mCherry-Lamp1 (red) are displayed in the merged images (A; left panels).  Bars, 10 µm.  
Movies were analysed using the TrackMate plug-in for ImageJ (Tinevez et al, 2016).  The 
trackplots displayed in the centre panels (A) indicate the movement of GFP-NRP2 vesicles 
with the speed of vesicle movement being denoted by a pseudocolour scale and the 
positions of stationary vesicles are indicated using purple circles.  The areas encompassed 
by the orange boxes in the centre panels are enlarged in right panels (A; zoom).  The 
number, size and velocity of GFP-NRP2 vesicles was calculated and these values are 
plotted in (B).  Values are mean ± SEM, number of cells is 26 (si-Con), 23 (si-Rab17) and 20 
(si-Vamp8), ***p<0.0001 Mann-Whitney test.   
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Figure 7.  NRP2 is required for invasiveness evoked by suppression of Rab17/Vamp8 
(A, B) MCF10ADCIS.com cells were transfected with siRNAs targeting Rab17 (si-Rab17), 
Vamp8 (si-Vamp8), NRP2 (si-NRP2 (SMARTPool) or an individual siRNA sequence 
(NRP2#1)) or a non-targeting control (si-Con) in the indicated combinations and plated on a 
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thin layer of Matrigel.  After 3 days of culture, cell were visualised using phase contrast 
microscopy and the circularity of individual acini was determined.  Bar: 50 μm (A). Circularity 
was measured in two independent experiments.  Values in (A) are mean ± SEM.  n=21 (si-
Con), n=15 (si-Rab17), n=12 (si-Vamp8), n=15 (si-NRP2), n=15 (si-Rab17 plus si-NRP2), 
n=12 (si-Vamp8 plus si-NRP2), n=71 (Con), n=143 (NRP2#1), n=140 (NRP2#1+Rab17), 
and n=121 (NRP2#1+Vamp8).  Kruskal Wallis test was performed (p<0.0001) and Dunn’s 
test for the multiple comparisons (***p<0.001). Then cells were fixed and laminin V and β4 
integrin were visualised by immunofluorescence (green signal and counterstained for F-actin 
(red signal) and nuclei (blue signal). Bar: 25 μm (B).   The Western blot in (A) indicates the 
efficiency of the NRP2 knockdown with tubulin used as a loading control.   
(C) MDA-MB-231 cells were transfected with siRNAs targeting Rab17 (si-Rab17), Vamp8 
(si-Vamp8), NRP2 (si-NRP2) or a non-targeting control (si-Con) in the indicated 
combinations and invasiveness into fibronectin-supplemented (25μg/ml) (Sigma-Aldrich) 
Matrigel was determined using an inverted invasion assay as for Fig. 4A. Values are mean ± 
SEM, n=6. Dunn’s test for multiple comparisons was performed (***p<0.001). 
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TABLE 1 
 
  Low membrane 
Vamp8 
% (n) 
High membrane 
Vamp8 
% (n) 
P-value 
Grade (n=542) 
I 
II 
III 
 
 
15 
43 
42 
 
(37)  
(108)  
(104) 
 
 
25 
44 
32 
 
(72)  
(128)  
(93)  
 
 
0.006 
 
 
Size (n=542) 
≤20 mm 
21-50 mm 
>50 mm 
 
 
64.4 
32.4 
3.2 
 
(161) 
(81) 
(8)  
 
 
56.5 
40.4 
3.1 
 
(165)  
(118)  
(9)  
 
0.104 
lymph node (n=538) 
negative 
positive 
 
 
59.4 
40.6 
 
(148)  
(101)  
 
 
55.8 
44.2 
 
(161)  
(128)  
 
 
0.383 
ER status (n=540) 
Negative 
Positive 
 
 
54.7 
45.3 
 
 
(135) 
(112) 
 
20.1 
79.9 
 
(59) 
(234) 
 
 
<0.001 
Her2 status (n=523) 
Negative 
Positive 
 
 
85.8 
14.2 
 
 
(199) 
(33) 
 
84.9 
15.1 
 
(247) 
(44) 
 
 
0.774 
 
 
Molecular subtype* (n=505)  
Luminal A 
Luminal B 
Triple-negative 
HER2-enriched 
 
 
36.2 
11.5 
39.4 
12.8 
 
 
(79) 
(25) 
(86) 
(28) 
 
55.1 
26.1 
12.5 
6.3 
 
 
(158) 
(75) 
(36) 
(18) 
 
 
<0.001 
Ki 67 (n=516) 
Low 
high 
 
 
80.8 
19.2 
 
(185) 
(44) 
 
 
74.2 
25.8 
 
(213) 
(74)  
 
 
0.076 
 
 
* Molecular subtype were defined as follows: Estrogen receptor (ER) or 
progesterone negative (PR) positive, HER2 negative and low Ki67 <14% for 
luminal A; ER or PR positive and Ki67 >14% or HER2 positive for luminal B; ER 
negative PR negative and HER2 positive for HER2 like; and ER negative PR 
negative and HER2 negative for triple negative. 
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Figure S1  Relationship between Rab17 levels and breast and ovarian cancer survival 
(A-D) Kaplan-Meier plots 
showing the relationship 
between Rab17 expression 
and overall survival in the 
indicated molecular 
subtypes of breast cancer. 
The red and black lines 
represent patients with 
Rab17 expression above 
and below the median 
respectively. Log rank test 
was performed in all cases. 
(A) Basal; n=1778 patients 
(low Rab17); n=1776 
patients (high Rab17). 
p=0.059. (B) Luminal A; 
n=884 patients (low Rab17); 
n=880 patients (high 
Rab17). p=0.00013. (C) 
Luminal B; n=500 patients 
(low Rab17); n=501 patients 
(high Rab17). p=0.00022. 
(D) HER2 positive; n=104 
patients (low Rab17); n=104 
patients (high Rab17). 
p=0.78.  
(E) Kaplan-Meier plot 
showing the relationship 
between Rab17 expression 
and overall survival in 
ovarian cancer; n=653 patients (low Rab17); n=652 patients (high Rab17). p=3 x10-5; Log rank 
test.  
(F)  Use of qPCR to confirm the siRNA knockdown of Rab17 for the transfections pertaining 
to the forward and reverse SILAC experiments.   
J. Cell Sci. 130: doi:10.1242/jcs.190835: Supplementary information
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Figure S2  Rab17 and Vamp8 knockdown, and STRING analysis of Rab17 interactome 
(A, B)  MDA-MB-231 
cells were transfected 
with siRNAs targeting 
Rab17 (si-Rab17), 
Vamp8 (si-Vamp8) or a 
non-targeting control 
(si-Con).  Levels of 
mRNA for Vamp8 (A) 
and Rab17 (B) were 
determined using qRT-
PCR. Data were 
normalised to GAPDH 
and values are mean ± 
SEM n>5.  Kruskal-
Wallis test was 
performed (p=0.0078) 
and Dunn’s test as 
“post-hoc” test for the 
multiple comparisons 
(**p<0.01). 
(C) A mutant of Vamp8 
lacking the 
transmembrane 
domain (Vamp8cyto) and 
GST-tagged-Rab17s 
(both the wild-type and 
a constitutively active 
GTPase-deficient 
mutant of the protein) 
were produced in E.Coli and purified.  Purified proteins were incubated together, following 
which GST-tagged Rab17s were captured using glutathione beads (pull-down).  The beads 
were washed and captured proteins were separated by SDS-PAGE and visualised using 
colloidal coomassie blue.   
(D) Most highly connected network of physical and functional protein-protein interactions 
within proteins of the Rab17 interactome (95 proteins) identified by STRING analysis. The 
network shows the significant links between components of the Rab17 interactome.  The 
nodes representing  the lysosome, SNARE complexes and Rab-protein signal transduction 
are highlighted.  Required confidence (score) = 0.4. 
J. Cell Sci. 130: doi:10.1242/jcs.190835: Supplementary information
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Figure S3  Colocalisation of Vamp8 with GFP-tagged late endosomal markers 
MDA-MB-231 cells were transfected with GFP-tagged CD63 (CD63-GFP; green) or GFP-
tagged Lamp1 (Lamp1-GFP; green).  24hr following transfection, cells were fixed and stained 
with antibodies recognising endogenous Vamp8 (red).  Nuclei were counterstained using 
DAPI (blue).  Bar, 10 μm.  The area encompassed by the white squares are shown on the 
panels on the right (zoom) 
J. Cell Sci. 130: doi:10.1242/jcs.190835: Supplementary information
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Figure S4  Knockdown and rescue of Rab17 and Vamp8 expression in 
MCF10ADCIS.com cells 
(A) MCF10ADCIS.com 
cells were transfected with 
an siRNA targeting Rab17 
(si-Rab17) or a non-
targeting control (si-Con) 
and the levels of mRNA for 
Rab17 determined using 
qRT-PCR. Cells were 
plated for 48, 72 and 96h 
after transfection. Data 
were normalised to 
GAPDH and values are 
expressed as means ± 
SEM.  
(B) MCF10ADCIS.com 
cells were transfected with 
a siRNAs targeting Rab17 (si-Rab17), Vamp8 (si-Vamp8) or a non-targeting control (si-Con), 
and levels of Vamp8 were determined using Western blot 48, 72 and 96 h after transfection. 
(C)  MCF10ADCIS.com cells were transfected with an siRNA targeting Rab17 (si-Rab17#1) 
or a non-targeting control (si-Con) in combination with a plasmid encoding an siRNA resistant 
form of GFP-Rab17 (GFP-Rab17resc).  The levels of mRNA for Rab17 were then determined 
using qRT-PCR. 
(D)  MCF10ADCIS.com cells were transfected with an siRNA targeting Vamp8 (si-Rab17#2) 
or a non-targeting control (si-Con) in combination with a plasmid encoding an siRNA resistant 
form of GFP-Vamp8 (GFP-Vamp8resc).  Levels of Vamp8 were then determined using Western 
blot with actin used as a loading control. 
(E) MCF10DCIS.com cells were transfected with siRNAs targeting Rab17 (Rab17), Vamp8 
(Vamp8), both alone or in combination (Rab17 + Vamp8), or a non-targeting control (Con) 
Cells were plated into Matrigel and cultured for 3 days, following which cells were fixed and 
acini were visualised using phase contrast microscopy. Circularity was determined by 
measuring the ratio between the width and length of each acini. Values are mean ± SEM, 
n=198 (Con), n=266 (Rab17), n=291 (Vamp8) and n=192 (Rab17 and Vamp8).  ** p<0.01, 
***p<0.001 Mann-Whitney test.   
J. Cell Sci. 130: doi:10.1242/jcs.190835: Supplementary information
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Click here to download spreadsheet 1 
SUPPLEMENTARY SPREADSHEETS 
Supplementary spreadsheet 1  SILAC analysis of the influence of Rab17 knockdown on 
the cellular proteome 
This spreadsheet supports the data presented in Fig. 1B.  MDA-MB-231 cells which were 
SILAC-labelled with heavy and light amino acids were transfected with non-targeting si-RNA 
(si-Con) or an si-RNA targeting Rab17 (si-Rab17) respectively (forward (Fw) experiment). For 
the reverse (Rev) experiment these labelling conditions were swapped.  Columns E and F 
indicate the SILAC ratio si-Rab17/si-Con (Log2 scale) of each protein obtained for Fw (si-
Rab17/si-Con) versus Rev experiment for the whole cell proteome. (Significance B statistic 
test, False discovery rate of 5%, Perseus software). 
J. Cell Sci. 130: doi:10.1242/jcs.190835: Supplementary information
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Click here to download spreadsheet 2 
Supplementary spreadsheet 2   Label-free MS analysis of the Rab17 interactome 
This spreadsheet supports the data presented in Fig. 2A.  MDA-MB-231 cells were transfected 
with GFP or Rab17-GFP.  GFP-tagged proteins were isolated using GFP-Trap_A agarose 
beads (Chromotek, Planegg, Alemania). Proteins eluted from the beads were resolved by 
SDS-PAGE, stained with Comassie blue (Expedeon, Cambrige, UK) and in-gel digested for 
MS analysis. Three independent replicates were generated per condition (column E-G; Con 
IP; column H-J, Rab17 IP).  Significantly enriched proteins were selected using a Welsh test-
based analysis (5% FDR). 
J. Cell Sci. 130: doi:10.1242/jcs.190835: Supplementary information
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Click here to download spreadsheet 3 
Supplementary spreadsheet 3   SILAC analysis of the influence of Rab17 knockdown 
on the surface and internalised proteomes of MDA-MB-231 cells 
This spreadsheet supports the data presented in Fig. 6A & B.  SILAC ratios (si-Rab17/si-Con) 
for the surface and internalised proteomes were determined for the forward a (Fw) and reverse 
(Rev) experiments and these are presented in columns E-H.  From the filtered list of quantified 
proteins, hits with opposite regulation (= opposite sign when SILAC ratio expressed as log2) 
in the two experiments were excluded. To identify differentially trafficked proteins upon Rab17 
knockdown, proteins belonging to the 1st or 3rd of the SILAC ratio distribution of the forward 
and reverse experiment were considered. This statistical approach allowed us to select 
proteins with small but reproducible (in both forward and reverse SILAC experiments) changes 
in localization. 
J. Cell Sci. 130: doi:10.1242/jcs.190835: Supplementary information
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SUPPLEMENTARY MOVIES 
J. Cell Sci. 130: doi:10.1242/jcs.190835: Supplementary information
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Supplementary movies 1 – 3  Fluorescence time-lapse imaging of GFP-NRP2 dynamics 
in living cells. 
MDA-MB-231 cells were transfected with GFP-tagged NRP2 and mCherry-tagged Lamp1 in 
combination with siRNAs targeting Rab17 (si-Rab17) (movie 2), Vamp8 (si-Vamp8) (movie 3) 
or a non-targeting control (si-Con) (movie 1).  Transfected cells were imaged by time-lapse 
fluorescence confocal microscopy.  Movies were captured with 0.85 sec frame intervals over 
a period of 2.85 min. 
J. Cell Sci. 130: doi:10.1242/jcs.190835: Supplementary information
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